Replies to post #2718 on Enanta Pharmaceuticals Inc (ENTA)

[DewDiligence]

I don’t consider VERU's drug a competitor; VERU's phase-3 trial is restricted to hospitalized patients with ARDS, which is not the market ENTA is seeking to address:

https://finance.yahoo.com/news/veru-reaches-agreement-fda-phase-123000795.html